Biogen starts dosing in Phase III trial of Friedreich ataxia therapy
Biogen has commenced dosing in the Phase III BRAVE study to assess omaveloxolone in children of two to less than …
Biogen has commenced dosing in the Phase III BRAVE study to assess omaveloxolone in children of two to less than …
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that includes a variety of differences or challenges with social communication and …
MSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan (I-DXd) …
With the 10-year Health Plan on the horizon, the NHS could learn some tricks from France, Germany and the Nordics. At …
Skyhawk Therapeutics has dosed the first subject in the randomised Phase II/III FALCON-HD trial of the oral small-molecule RNA splicing …
US Food and Drug Administration (FDA) Commissioner Dr. Marty Makary addressed concerns about the recent cuts impacting the agency’s ability …
Oncology clinical trials are complex and costly, making a successful setup critical. Facing challenges such as long timelines and patient …
Lyell Immunopharma has reported new clinical data from the Phase I/II clinical trial of autologous dual-targeting CD19/CD20 chimeric antigen receptor …
Ventyx Biosciences has reported encouraging top-line outcomes from its single-centre Phase IIa trial of the central nervous system (CNS)-penetrant NLRP3 …
Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent …
Cell and gene therapies represent a groundbreaking advancement in medical science, offering transformative opportunities for treating complex and previously untreatable …
Clarametyx Biosciences has received approval from the Independent Data Monitoring Committee (DMC) to progress its Phase Ib/IIa trial of CMTX-101, an …
The US Food and Drug Administration (FDA) has approved Ocugen’s investigational new drug (IND) amendment to initiate a Phase II/III …
At the 2025 European Hematology Association (EHA) Congress, held from June 12 to June 15 in Milan, Italy, updated results …
According to the World Health Organization, endometriosis affects approximately one in ten women and girls of reproductive age globally. There …